Stay updated on Pembrolizumab in Pancreatic Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Pancreatic Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedAdded a dedicated Locations section listing study sites by state (Arizona, Connecticut, Florida, Massachusetts, Texas, Virginia) and updated to revision v3.3.3. Removed the separate state-specific 'Locations' subsections (Arizona Locations, Connecticut Locations, etc.) from the prior revision.SummaryDifference0.7%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2 on the page; no study content was altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check48 days agoChange DetectedRemoved the government funding/operating status notice banner from the page, which previously warned users about potential delays and where to check operating status. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedThe screenshots show essentially the same study details page with no substantial edits to core content such as eligibility criteria, interventions, or outcomes; only minor UI/formatting differences. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check91 days agoChange DetectedAdded a government-funding notice and updated the version to v3.2.0, while removing the old v3.1.0 version tag.SummaryDifference5%

- Check98 days agoChange DetectedUpdated to Revision: v3.1.0 with expanded contact emails/phone numbers; removed obsolete revision v3.0.2. No changes detected to pricing, stock, or time slots.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Pancreatic Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Pancreatic Cancer Clinical Trial page.